Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
11.75
-0.07 (-0.59%)
At close: Sep 30, 2025, 4:00 PM EDT
11.75
0.00 (0.00%)
After-hours: Sep 30, 2025, 4:10 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $329.49 million as of September 30, 2025. Its market cap has decreased by -29.04% in one year.
Market Cap
329.49M
Enterprise Value
159.76M
1-Year Change
-29.04%
Ranking
Category
Stock Price
$11.75
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $329.49M, a decrease of -18.06%. That is a compound annual growth rate of -12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 331.46M | -12.23% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.21B |
| Johnson & Johnson | 437.40B |
| AbbVie | 394.23B |
| UnitedHealth Group | 312.62B |
| Novo Nordisk | 245.50B |
| Novartis AG | 240.62B |
| Abbott Laboratories | 231.67B |
| AstraZeneca | 231.02B |